Analgesics in New Zealand

Analgesics in New Zealand

  • October 2016
  • 25 pages
  • Euromonitor International
Report ID: 149691
2016 saw analgesics face negative media coverage as it was discovered that various pain relief products with the same active ingredients were being marketed for different ailments. In particular, Reckitt Benckiser in Australia was found to be marketing the same active ingredient in different products for specific ailments, such as back pain, neck pain and menstrual pain. The federal court in Australia ordered the company to stop selling some of its products under the Nurofen brand as they contai...

Euromonitor International’s Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

ANALGESICS IN NEW ZEALAND
Euromonitor International
October 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2011-2016
Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Reckitt Benckiser New Zealand Ltd in Consumer Health (new Zealand)
Strategic Direction
Key Facts
Summary 1 Reckitt Benckiser New Zealand Ltd: Key Facts
Competitive Positioning
Summary 2 Reckitt Benckiser New Zealand Ltd: Competitive Position 2016
Executive Summary
Healthy Value Growth Driven by A Buoyant Economy
Natural Approach To Health A Key Driver of Sales
Vitamins and Dietary Supplement Companies Perform Well
Supermarkets Slightly Gain Share
Value Growth Likely To Be Restrained by the Supermarket Channel
Key Trends and Developments
Natural Health and Supplementary Products Bill Update
Mergers and Acquisitions Strengthen Key Categories
Convenient Delivery Formats Grow in Popularity
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 3 OTC: Switches 2014-2016
Definitions
Sources
Summary 4 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Country=NewZealand Industry=OTC ParentIndustry=Pharmaceutical Date=201610 Topic=MarketReport Publisher=EuromonitorInternational Price=1000